PODD

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Insulet Corporation

Insulet Corporation , headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.
CEO
Shacey Petrovic
Employees
1900
Headquarters

100 Nagog Park
Acton, Massachusetts 01720-3440
Phone: 19786007000
www.myomnipod.com

News

Insulet Recent Insider Activity
Nov 22, 2022 15:06pm

Bret Christensen , EVP and CCO at Insulet (NASDAQ: PODD ), reported a large insider sell on November 21, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Christensen sold 3,000 shares of Insulet . The total transaction amounted to $885,449. Insulet shares are trading down 1.67% at $285.75 at the time of this writing on Tuesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. The Importance of Insider Transactions Insider transactions shouldn''t be used primarily to make … Full story available on Benzinga.com


Source:Benzinga
Medical Device Maker Insulet Is Poised for an Upside Breakout
Nov 16, 2022 12:18pm

Insulet Corp. (PODD) is poised for an upside breakout, writes technical analyst Bruce Kamich, who says the stock of the maker of insulin delivery systems went through a long basing pattern but has been moving higher of late….PODD


Source:The Street RealMoney
Insulet Issues Medical Device Correction For Omnipod 5 Controller
Nov 16, 2022 05:26am

Medical device company Insulet Corp. announced a medical device correction for its Omnipod 5 Automated Insulin Delivery System. The decision is due to an issue with the Omnipod 5 Controller charging port and cable. In a statement, the Massachusetts-based company said it has received 24 reports that the Omnipod 5 Controller charging port (USB-C port) or cable (USB cable) are melting, deforming…


Source:RTT News
Insulet Issues Medical Device Correction For Omnipod 5 Controller Due To Faulty Charging
Nov 15, 2022 15:26pm

Insulet Corporation (NASDAQ: PODD ) announced a Medical Device Correction for the Omnipod 5 Automated Insulin Delivery System because of an issue with the Omnipod 5 Controller charging port and cable. Insulet has received 24 reports that the Omnipod 5 Controller charging port (USB-C port) or cable (USB cable) is melting, deforming or discoloring due to heat generated by … Full story available on Benzinga.com


Source:Benzinga
Insulet Issues a Nationwide Voluntary Medical Device Correction for the Omnipod® 5 Controller
Nov 14, 2022 21:30pm

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), today announced a Medical Device Correction for the Omnipod® 5 Automated Insulin Delivery System because of an issue with the Omnipod 5 Controller charging port and cable. This does not impact the Omnipod 5 Pod, the Omnipod® DASH Insulin Management System, the Omnipod® Insulin Management System, or compatible Android smartphone devices that have the Omnipod 5 App installed. These actions are taken volunt


Source:Business Wire
Insulet Issues a Nationwide Voluntary Medical Device Correction for the Omnipod 5 Controller
Nov 14, 2022 21:30pm

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), today announced a Medical Device Correction for the Omnipod 5 Automated Insulin Delivery System because of an issue with the Omnipod 5 Controller charging port and cable. This does not impact the Omnipod 5 Pod, the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, or compatible Android smartphone devices that


Source:Wallstreet:Online
Insulet Corporation (PODD) is an excellent investment, but the stock is overvalued/undervalued right now
Nov 11, 2022 14:54pm

Insulet Corporation (NASDAQ:PODD) closed Thursday at $304.96 per share, up from $294.93 a day earlier. While Insulet Corporation has overperformed by 3.40%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PODD fell by -0.88%, with highs and lows ranging from $324.81 to $181.00, whereas the simple […]


Source:US Post News
New york - Expedia, Starbucks rise; Carvana, Syneos Health fall
Nov 04, 2022 21:23pm

NEW YORK - Stocks that traded heavily or had substantial price changes Friday: Insulet Corp., up $57.65 to $313. The maker of insulin infusion systems raised its revenue…


Source:Business Mag
Insulet Issued Voluntary Medical Device Correction for Omnipod DASH Personal Diabetes Manager on October 17, 2022
Nov 04, 2022 20:01pm

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), announced on October 17, 2022, a Medical Device Correction for all Omnipod DASH Personal Diabetes Managers (PDMs) distributed globally. This action was taken voluntarily with the knowledge of the FDA and other regulatory agencies. Insulet received reports from Omnipod DASH users regarding PDM battery issues, including battery swelling


Source:Wallstreet:Online
Insulet Issued Voluntary Medical Device Correction for Omnipod DASH® Personal Diabetes Manager on October 17, 2022
Nov 04, 2022 20:01pm

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), announced on October 17, 2022, a Medical Device Correction for all Omnipod DASH® Personal Diabetes Managers (PDMs) distributed globally. This action was taken voluntarily with the knowledge of the FDA and other regulatory agencies. Insulet received reports from Omnipod DASH users regarding PDM battery issues, including battery swelling and leakage, and in rare cases, extreme overheating, which has result


Source:Business Wire
Insulet stock soars 17% on Q3 beat, raised FY22 revenue outlook
Nov 04, 2022 16:39pm

Insulet (PODD) stock rose ~17% on Friday after Q3 results beat estimates and the company raised its revenue growth outlook.Adjusted EPS amounted to $0.45, surpassing estimates


Source:Seeking Alpha
Why Insulet Stock Is Skyrocketing Today
Nov 04, 2022 15:13pm

Investors are cheering the company''s strong Q3 results.


Source:The Motley Fool
Insulet Corporation PT Raised to $300 at Stifel
Nov 04, 2022 12:44pm

https://www.investing.com/news/pro/insulet-corporation-pt-raised-to-300-at-stifel-432SI-2933013


Source:Investing.com
Insulet Shares Jump After Q3 Earnings Surpass Expectations, Improved Annual Guidance
Nov 04, 2022 10:22am

Insulet Corp (NASDAQ: PODD ) posted an adjusted EPS of $0.45 in Q3 , surpassing the consensus of $0.15. Insulet recorded a bottom-line dip into the red of $(5.2) million from profits of $12.6 million a year ago. However, the company registered sales growth of 23.7% Y/Y to $340.8 million, beating the consensus of $312.52 million. The company reported total Omnipod automated insulin … Full story available on Benzinga.com


Source:Benzinga
Insulet Corporation (PODD) Q3 2022 Earnings Call Transcript
Nov 04, 2022 00:56am

Insulet Corporation (NASDAQ:NASDAQ:PODD) Q3 2022 Earnings Conference Call November 03, 2022, 04:30 PM ET Company Participants Deborah Gordon - Vice President, Investor Relations Jim…


Source:Seeking Alpha
November 3, 2022 4:30 PM EDT : Q3 2022 Insulet Corporation Earnings Conference Call
Nov 03, 2022 20:30pm

The Investor Relations website contains information about Insulet Corporation''s business for stockholders, potential investors, and financial analysts.


Source:Investor Insulet
Insulet Reports Third Quarter 2022 Revenue Increase of 24% Year-Over-Year (29% Constant Currency1)
Nov 03, 2022 20:01pm

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced financial results for the three months ended September 30, 2022. Third Quarter Financial Highlights: Third quarter 2022 revenue of $340.8 million, up 23.7%, or 28.5% in constant currency1, compared to $275.6 million in the prior


Source:Wallstreet:Online
Insulet Reports Third Quarter 2022 Revenue Increase of 24% Year-Over-Year (29% Constant Currency¹)
Nov 03, 2022 20:01pm

ACTON, Mass. --(BUSINESS WIRE)--Nov. 3, 2022-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced financial results for the three months ended September 30, 2022 .


Source:Investor Insulet
Insulet warns of battery issues with some Omnipod Dash PDM devices
Nov 03, 2022 00:00am

Insulet (Nasdaq:PODD) recently issued a voluntary safety notice in Europe to warn of certain issues with its Omnipod Dash system. The Omnipod Dash is Insulet’s previous-generation insulin pump. The company since launched its FDA-cleared and CE-marked Omnipod 5 next-generation automated insulin delivery system. Insulet’s notice went out to current and past users of the Omnipod […]


Source:WTWH
Here’s what diabetes tech companies are doing for National Diabetes Awareness Month
Nov 01, 2022 00:00am

As we enter November, we enter National Diabetes Awareness Month. A number of diabetes technology developers plan to mark that in a special way. Dexcom (Nasdaq:DXCM), Insulet (Nasdaq:PODD) and Embecta (Nasdaq:EMBC) all announced their plans to celebrate. Last year, a handful of companies marked the month — which includes World Diabetes Day (Nov. 14) — […]


Source:WTWH
Insulet Stock: Overpriced Play In The Medical Space (PODD)
Oct 18, 2022 07:36am

Insulet Corp. has an interesting business model and management continues to grow the company''s top line nicely. But see why I rate PODD stock a Sell.


Source:Seeking Alpha
Equities Analysts Offer Predictions for Insulet Co.’s Q3 2022 Earnings (NASDAQ:PODD)
Oct 15, 2022 17:01pm

Analysts at Jefferies Financial Group issued their Q3 2022 earnings per share estimates for shares of Insulet in a report issued on Tuesday, October 11th. Jefferies Financial Group analyst M. Taylor … Read Full Story at source (may require registration) The post Equities Analysts Offer Predictions for Insulet Co.’s Q3 2022 Earnings (NASDAQ:PODD) appeared first on ForexTV .


Source:ForexTV